Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Asia Pacific Dietary Supplements Market would witness market growth of 10.3% CAGR during the forecast period (2017 - 2023). The Asia Pacific region accounted for maximum revenue of dietary supplements market, in 2016. Growing awareness about the need for nutritional supplements in China and India would act favorably for the market. Growing need for microencapsulation within the nutraceuticals industry to ensure the controlled release of ingredients, coupled with maintaining the color characteristics would propel the supplements manufacturers to use capsule dosage forms.
The demand for a powdered form of supplements is set to witness a prominent CAGR during the forecast period, as energy-mix powders are growing in popularity among athletes and bodybuilders. Based on Product, the Dietary Supplements market segments the market into
TABLEts & Capsules, Powder, Liquids, Soft Gels, and Others.
Based on Ingredients, the market report segments the market into Vitamins & Minerals, Botanicals, Amino Acids, and Enzymes & Others. Based on End User, the Dietary Supplements market segments the market into Adults, Children, Infants & Old Aged, and Pregnant Woman. Based on Regions, the Dietary Supplements market segments the market into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stakeholders of the Asia Pacific Dietary Supplements Market. Key companies profiled in the report include Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.